Lynn A. Tetrault, Director at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 41,050 shares at $50.04 ($2.0M) on 2024-09-09, disclosed to the SEC on 2024-09-11.
Scheduled sale ($2.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.04 | 3,199 | $160K | 7.8% |
| 2 | $50.04 | 3,199 | $160K | 7.8% |
| 3 | $49.05 | 8,490 | $416K | 20.4% |
| 4 | $49.05 | 8,490 | $416K | 20.4% |
| 5 | $50.20 | 8,661 | $435K | 21.3% |
| 6 | $50.20 | 8,661 |
| $435K |
| 21.3% |
| 7 | $50.60 | 350 | $18K | 0.9% |
| Total | $49.70 avg | 41,050 | $2.0M | 100% |
| Filing → |
| NEO | SELL | 2026-06-11 | $60K | — | Filing → |
| NEO | BUY | 2025-05-09 | $114K | — | Filing → |
| RYTM | SELL | 2024-08-28 | $215K | — | Filing → |